On the relevance of the NPY2-receptor variation for modes of action cascading processes

NeuroImage

Volumn 102, Issue P2, 2014, Pages 558-564

  Beste, Christian ^a   Stock, Ann Kathrin ^a   Epplen, Jörg T ^b,c   Arning, Larissa ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

Action control; EEG; NPY2R; P3; Processing modes; Promoter variation

Indexed keywords

NEUROPEPTIDE Y2 RECEPTOR; NEUROPEPTIDE Y RECEPTOR;

ADULT; ALLELE; ANTERIOR CINGULATE; ARTICLE; ATTENTION; BEHAVIOR; BRAIN FUNCTION; COGNITION; ELECTROENCEPHALOGRAM; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NEUROPHYSIOLOGY; NORMAL HUMAN; NPY2R GENE; PROMOTER REGION; TASK PERFORMANCE; THETA RHYTHM; BIOLOGICAL MODEL; BRAIN; DECISION MAKING; ELECTROENCEPHALOGRAPHY; GENETICS; PHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; YOUNG ADULT;

ADULT; BRAIN; CHOICE BEHAVIOR; ELECTROENCEPHALOGRAPHY; FEMALE; GENETIC VARIATION; HUMANS; MALE; MODELS, NEUROLOGICAL; PROMOTER REGIONS, GENETIC; PSYCHOMOTOR PERFORMANCE; RECEPTORS, NEUROPEPTIDE Y; YOUNG ADULT;

EID: 84907161237     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2014.08.026     Document Type: Article

References (43)

1. Adewale A.S., Macarthur H., Westfall T.C. Neuropeptide Y induced modulation of dopamine synthesis in the striatum. Regul. Pept. 2005, 129:73-78.
2. Adewale A.S., Macarthur H., Westfall T.C. Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors. Neuropharmacology 2007, 52:1396-1402.
3. Aoki C., Pickel V.M. Neuropeptide Y in cortex and striatum. Ultrastructural distribution and coexistence with classical neurotransmitters and neuropeptides. Ann. N. Y. Acad. Sci. 1990, 611:186-205.
4. Arning L., Stock A.-K., Kloster E., Epplen J.T., Beste C. NPY2-receptor variation modulates iconic memory processes. Eur. Neuropsychopharmacol. 2014, 10.1016/j.euroneuro.2014.03.003.
5. Beste C., Saft C. Action cascading in a possible model of striatal medium spiny neuron dysfunction: behavioral and EEG data in a patient with benign hereditary chorea. Brain Struct. Funct. 2013, 10.1007/s00429-013-0649-9.
6. Beste C., Konrad C., Uhlmann C., Arolt V., Zwanzger P., Domschke K. Neuropeptide S receptor (NPSR1) gene variation modulates response inhibition and error monitoring. NeuroImage 2013, 71:1-9.
7. Caberlotto L., Fuxe K., Hurd Y.L. Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum. J. Chem. Neuroanat. 2000, 20:327-337.
8. Decressac M., Barker R.A. Neuropeptide Y and its role in CNS disease and repair. Exp. Neurol. 2012, 38:265-272.
9. Decressac M., Pain S., Chabeauti P.Y., Frangeul L., Thiriet N., Herzog H., Vergote J., Chalon S., Jaber M., Gaillard A. Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease. Neurobiol. Aging 2012, 33:2125-2137.
10. Fuchs M., Kastner J., Wagner M., Hawes S., Ebersole J.S. A standardized boundary element method volume conductor model. Clin. Neurophysiol. 2002, 113:702-712.
11. Herrmann C.S., Knight R.T. Mechanisms of human attention: event-related potentials and oscillations. Neurosci. Biobehav. Rev. 2001, 25:465-476.
12. Huster R.J., Enriquez-Geppert S., Lavallee C.F., Falkenstein M., Herrmann C.S. Electroencephalography of response inhibition tasks: functional networks and cognitive contributions. Int. J. Psychophysiol. 2013, 87:217-233.
13. Kloster E., Saft C., Akkad D.A., Epplen J.T., Arning L. Association of age at onset in Huntington's disease with functional promoter variations in NPY and NPY2R. J. Mol. Med. 2014, 92:177-184.
14. Logan G.D., Cowan W.B. On the ability to inhibit thought and action: a theory of an act of control. Neurosci. Biobehav. Rev. 1984, 33:647-661.
15. Marco-Pallares J., Grau C., Ruffini G. Combined ICA-LORETA analysis of is match negativity. Neuroimage 2005, 25:471-477.
16. Mazziotta J., Toga A., Evans A., Fox P., Lancaster J., Zilles K., et al. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos. Trans. R. Soc. Lond. B Biol. Sci. 2001, 356:1293-1322.
17. Mu¨ckschel M., Stock A.-K., Beste C. Psychophysiological mechanisms of interindividual differences in goal activation modes during action cascading. Cereb. Cortex 2013, 10.1093/cercor/bht066.
18. Ness V., Beste C. The role of the striatum for goal activation of cascaded actions. Neuropsychologia 2013, 51:2562-2571.
19. Nunez P.L., Pilgreen K. The spline-Laplacian in clinical neurophysiology: a method to improve EEG spatial resolution. J. Clin. Neurophysiol. 1991, 8:397-413.
20. Ocklenburg S., Gu¨ntu¨rku¨n O., Beste C. Lateralized neural mechanisms underlying the modulation of response inhibition processes. Neuroimage 2011, 55:1771-1778.
21. Pascual-Marqui R.D. Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. Methods Find. Exp. Clin. Pharmacol. 2002, 24:5-12.
22. Polich J. Updating P300: an integrative theory of P3a and P3b. Clin. Neurophysiol. 2007, 118:2128-2148.
23. Preacher K., Hayes A. SPSS and SAS procedures for estimating indirect effects in simple mediation models. Behav. Res. Methods Instrum. Comput. 2004, 36:717-731.
24. Roach B.J., Mathalon D.H. Event-related EEG time-frequency analysis: an overview of measures and an analysis of early gamma band phase locking in schizophrenia. Schizophr. Bull. 2008, 34:907-926.
25. Roubos E.W., Spooren W.P., Martens G.J., Veening J.G., Cools A.R. NPY-mRNA expression in the nucleus accumbens, caudate putamen and cerebral cortex of apomorphine-susceptible and apo-morphine-unsusceptible rats. Cell Tissue Res. 2003, 313:209-215.
26. Schultz W. Multiple dopamine functions at different time courses. Annu. Rev. Neurosci. 2007, 30:259-288.
27. Schwarz W., Ischebeck A. On the interpretation of response time vs onset asynchrony functions: application to dual-task and precue-utilization paradigms. J. Math. Psychol. 2001, 45:452-479.
28. Sekihara K., Sahani M., Nagarajan S.S. Localization bias and spatial resolution of adaptive and non-adaptive spatial filters for MEG source reconstruction. Neuroimage 2005, 25:1056-1067.
29. Sigman M., Dehaene S. Brain mechanisms of serial and parallel processing during dual-task performance. J. Neurosci. 2008, 28:7585-7598.
30. Sobel M.E. Asymptotic confidence intervals for indirect effects in structural equation models. Sociological Methodology 1982, 290-312. Jossey-Bass, SanFrancisco. S. Leinhart (Ed.).
31. Stanic D., Brumovsky P., Fetissov S., Shuster S., Herzog H., Ho¨kfelt T. Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals. J. Comp. Neurol. 2006, 499:357-390.
32. Stock A.-K., Blaszkewicz M., Beste C. Effects of binge drinking on action cascading processes: an EEG study. Arch. Toxicol. 2014, 88:475-488.
33. Stock A.-K., Arning L., Epplen J.T., Beste C. DRD1 and DRD2 genotypes modulate processing modes of goal activation processes during action cascading. J. Neurosci. 2014, 34:5335-5341.
34. Stock A.-K., Heintschel von Heinegg E., Ko¨hling H.L., Beste C. Latent toxoplasma gondii infection leads to improved action control. Brain Behav. Immun. 2014, 37:103-108.
35. Tallon-baudry C., Bertrand O., Delpuech C., Pernier J. Oscillatory gamma-band (30-70Hz) activity induced by a visual search task in humans. J. Neurosci. 1997, 17:722-734.
36. Tepper J.M., Tecuapetla F., Koos T., Ibanez-Sandoval O. Heterogeneity and diversity of striatal GABAergic interneurons. Front. Neuroanat. 2010, 4:150.
37. Thiriet N., Deng X., Solinas M., Ladenheim B., Curtis W., Goldberg S.R., Palmiter R.D., Cadet J.L. Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum. J. Neurosci. 2005, 25:5273-5279.
38. Trantham-Davidson H., Neely L.C., Lavin A., Seamsn J.K. Mechanisms underlying D1 versus D2 dopamine receptor regulation of inhibition in prefrontal cortex. J. Neurosci. 2004, 24:10652-10659.
39. Verbruggen F., Schneider D.W., Logan G.D. How to stop and change a response: the role of goal activation in multitasking. J. Exp. Psychol. Hum. Percept. Perform. 2008, 34:1212-1228.
40. Verleger R., Jaskowski P., Wascher E. Evidence for an integrative role of P3b in linking reaction to perception. J. Psychophysiol. 2005, 19:165-181.
41. Yildiz A., Wolf O.T., Beste C. Stress intensifies demands on response selection during action cascading processes. Psychoneuroendocrinology 2014, 42:178-187.
42. Yildiz A., Quetscher C., Dharmadhikari S., Chmielewski W., Glaubitz B., Schmidt-Wilcke T., Edden R., Dydak U., Beste C. Feeling safe in the plane: neural mechanisms underlying superior action control in airplane pilot trainees - a combined EEG/MRS study. Hum. Brain Mapp. 2014, 10.1002/hbm.22530.
43. Yordanova J., Kolev V. Single-sweep analysis of the theta frequency band during an auditory oddball task. Psychophysiology 1998, 35:116-126.